2011Jilin yixueRequires access

A comparative study of aripiprazole and risperidone in the treatment of female schizophrenia

Kong Xiang-juan

Open publisher page 1 citations

Abstract

Objective To compare the efficacy and side effects of aripiprazole and risperidone in the treatment of female schizophrenics.Methods 62 patients with female schizophrenics were randomly assigned to receive either aripiprazole group(n=31) or risperidone group(n=31).The therpeutic period was eghit weeks.Study used positive and negative symptoms scale(PANSS) were used to evaluate the efficacy and the treatment emergent symptoms scale to evaluate the safety.Results There were no significant differences between aripiprazole group and risperidone group in improved rate(87.10% and 90.32%).Aripiprazole group side effects less than risperidone group(P0.05).Conclusion Aripiprazole has similar efficacy as risperidone in treatment of female schizophrenic patients,with lighter side effects,less likely to cause weight gain and endocrine disorders.

About this research paper

What this paper is about

Objective To compare the efficacy and side effects of aripiprazole and risperidone in the treatment of female schizophrenics.Methods 62 patients with female schizophrenics were randomly assigned to receive either aripiprazole group(n=31) or risperidone group(n=31).The therpeutic period was eghit weeks.Study used positive and negative symptoms scale(PANSS) were used to evaluate the efficacy and the treatment emergent symptoms scale to evaluate the safety.Results There were no significant differences between aripiprazole group and risperidone group in improved rate(87.10% and 90.32%).Aripiprazole group side effects less than risperidone group(P0.05).Conclusion Aripiprazole has similar efficacy as risperidone in treatment of female schizophrenic patients,with lighter side effects,less likely to cause weight gain and endocrine disorders.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To compare the efficacy and side effects of aripiprazole and risperidone in the treatment of female schizophrenics.Methods 62 patients with female schizophrenics were randomly assigned to receive either aripiprazole group(n=31) or risperidone group(n=31).The therpeutic period was eghit weeks.Study used positive and negative symptoms scale(PANSS) were used to evaluate the efficacy and the treatment emergent symptoms scale to evaluate the safety.Results There were no significant differences between aripiprazole group and risperidone group in improved rate(87.10% and 90.32%).Aripiprazole group side effects less than risperidone group(P0.05).Conclusion Aripiprazole has similar efficacy as risperidone in treatment of female schizophrenic patients,with lighter side effects,less likely to cause weight gain and endocrine disorders.

Key concepts: Aripiprazole, Risperidone, Medicine, Schizophrenia (object-oriented programming), Negative symptom, Internal medicine, Side effect (computer science), Psychiatry

Related papers

Back to paper searchBrowse research topicsOriginal source
A comparative study of aripiprazole and risperidone in the treatment of female schizophrenia — Research Paper | ScholarLens